# Copart, Inc. (CPRT)

> Source: Nexqual · https://nexqual.com/CPRT · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Copart, Inc. (CPRT), nexqual.com/CPRT" · informational, not investment advice.

**Price:** USD 29.09 (+5.46% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 27.59 · day 27.7–29.28 · 52w 25.72–45.26 · market cap $26.9B · NMS

## Key facts
- Last four reported quarters (through Jul 31, 2026): revenue $4.67B, net income $1.48B (31.8% margin), free cash flow $1.27B (SEC filings).
- Valuation: P/E 18.2x (avg 28.2x at the last 3 fiscal year-ends).
- 6 of 80 tracked superinvestors hold CPRT (13F, Q2 2026): 0 new, 2 added, 4 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 4 Form 4 filings, $4.5M; 3 not under a Rule 10b5-1 plan ($3.6M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.25 on a 1–5 scale) (12 analysts), mean target USD 39 (range 25–55).
- Total return with dividends: 1Y -34.9% vs S&P 500 +14.9%; 5Y -23.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-19, EPS estimate USD 0.4, revenue estimate $1.19B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.50B | $3.87B | $4.24B | $4.65B | $4.67B | $4.67B |
| Operating income | $1.37B | $1.49B | $1.57B | $1.70B | $1.65B | $1.65B |
| Net income | $1.09B | $1.24B | $1.36B | $1.55B | $1.48B | $1.48B |
| EPS (diluted) | $1.13 | $1.28 | $1.40 | $1.59 | $1.55 | — |
| Free cash flow | $839M | $848M | $962M | $1.23B | $1.27B | $1.27B |
| Operating margin | 39.3% | 38.4% | 37.1% | 36.5% | 35.4% | 35.4% |
| Net margin | 31.1% | 32.0% | 32.2% | 33.4% | 31.8% | 31.8% |
| Revenue growth | +30.0% | +10.5% | +9.5% | +9.7% | +0.4% | — |
| Cash + short-term investments | $1.38B | $957M | $1.51B | $2.78B | $1.91B | — |
| Total debt | $2.0M | $11.0M | $0K | — | — | — |
Fiscal years end Jul. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jul 31, 2026)
P/E 18.2x · P/S 5.8x · P/FCF 21.3x · P/B 3.0x · FCF yield 4.70% · Earnings yield 5.51%
P/E at fiscal year-ends: Jul 2026 18.8x, Jul 2025 28.5x, Jul 2024 37.4x.

## Superinvestors (SEC 13F-HR, Q2 2026)
6 of 80 tracked investors hold CPRT. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Chuck Akre | Akre Capital Management | 4.41% | $225M | Reduced -0.2% |
| David Rolfe | Wedgewood Partners | 2.61% | $12.6M | Reduced -3.2% |
| Jensen Investment Management |  | 0.85% | $35.1M | Reduced -22.4% |
| AKO Capital |  | 0.43% | $18.5M | Added +139.6% |
| Yacktman Asset Management |  | 0.05% | $3.9M | Added +24.0% |
| Francois Rochon | Giverny Capital | 0.01% | $233K | Reduced -69.9% |

## Insider sales (SEC Form 4, open-market, last ~7 months)
1 of 4 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | Morefield Diane M | Director | 20,000 | $553K | 28.6% | No | Too little history (no open-market trades in 2023 or 2025) |
| 2026-07-28 | Liaw Jeffrey | Chief Executive Officer | 27,745 | $846K | 21.8% | Yes (adopted April 15, 2025) | Too little history (no open-market trades in 2023 or 2024) |
| 2026-07-13 | Englander Daniel J | Director | 80,000 | $2.2M | 13.5% | No | Too little history (no open-market trades in 2023) |
| 2026-04-15 | Liaw Jeffrey | Chief Executive Officer | 26,213 | $870K | 24.8% | No | Too little history (no open-market trades in 2023 or 2024) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.25 on a 1–5 scale), 12 analysts; mean target USD 39 (low 25, high 55).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-28 | BNP Paribas | Target raised | Outperform | $40 → $43 |
| 2026-09-17 | HSBC | Downgrade | Buy → Hold | $36 |
| 2026-09-14 | Freedom Broker | Target lowered | Buy | $39 → $36 |
| 2026-09-11 | Barrington Research | Upgrade | Market Perform → Outperform | $40 |
| 2026-09-11 | Baird | Target lowered | Outperform | $42 → $38 |
| 2026-09-03 | JP Morgan | Upgrade | Neutral → Overweight | $32 → $40 |
| 2026-08-26 | Barclays | Target lowered | Underweight | $26 → $25 |
| 2026-08-20 | Stephens & Co. | Reiterated | Equal-Weight | $35 |
| 2026-07-22 | Barclays | Target lowered | Underweight | $32 → $26 |
| 2026-06-26 | Freedom Broker | Initiated | Buy | $39 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -34.9% | -23.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -35.0% | -5.2% |
| Volatility (annualized) | 32.4% | 26.6% |
| Max drawdown | -41.2% (Oct 2025→Oct 2026) | -57.4% (May 2025→Sep 2026) |

## Peers (Specialty Business Services)
GPN (Global Payments Inc.) USD 85.88 +2.81% · RBA (RB Global, Inc.) USD 84.39 +2.91% · ULS (UL Solutions Inc.) USD 73.63 -0.88% · ARMK (Aramark) USD 52.52 -5.73% · TRI (Thomson Reuters Corp) USD 123.26 +6.94% · RTO (Rentokil Initial plc) USD 22.88 +8.75%

## More
Full page: https://nexqual.com/CPRT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by product line (quarter ended 2026-07-31)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Service | $969.5M | 84.1% | +1.4% |
| Product | $182.9M | 15.9% | +8.3% |
| Total revenue | $1.15B | 100% | — |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-10-31) | $0.40 | $0.41 | -2.7% | $1.19B | 7 |
| Next quarter (ends 2027-01-31) | $0.36 | $0.39 | -7.9% | $1.33B | 1 |
| Current fiscal year (ends 2027-07-31) | $1.63 | $1.68 | -3.4% | $5.49B | 4 |
| Next fiscal year (ends 2028-07-31) | $1.81 | $1.85 | -2.2% | $6.22B | 4 |